Fritextsökning
Innehållstyper
-
New map of eye proteins
A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.
-
Anställer tolv nya bioinformatiker
Plattformen för bioinformatik växer och Scilifelab startar upp ett mentorprogram.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Två nya bolag i huben
Tataa och Promimic tar plats i Astrazenecas Bio Venture Hub.
-
Sverige populärast på BIO2009
Rekordmånga besökare kom for att höra Jonas Frisén från Karolinska Institutet berätta om svensk stamcellsforskning.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Han tar över på Scilifelab
Olli Kallioniemi tar över direktörsrollen efter Mathias Uhlén.
-
Nytt center tar över där företagen misslyckas
Amerikanska läkemedelsbolag tar inte fram nya mediciner tillräckligt snabbt. Därför inrättar landets regering ett nytt center som tar över olönsamma projekt.
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
LEO Pharma - International Clinical Trial Manager
-
Ideon - Sweden's oldest science park
Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...
-
With their hands on the legal levers
It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.
-
Vill ha feedback på riktlinjer för genterapier
EMA har publicerat ett utkast med riktlinjer för bland annat utveckling, kliniska studier och uppföljning av genterapier.
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
New partnering platform
EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Lidds får USA-patent
Utökar skyddet för sin behandling mot prostatacancer.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Smuggling för miljarder
Läkemedel för 200 miljarder dollar - så stort är värdet på förfalskningsmarknaden visar en ny undersökning.
-
Diagnostics to deal with new diseases
Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...